Searching…
A number of researchers and pharmaceutical companies are either currently working on, or are considering working on or investing in, the development of drugs or precision therapies that may improve the lives of those ...
CHD2 myoclonic encephalopathy is a condition characterized by recurrent seizures (epilepsy), abnormal brain function (encephalopathy), and intellectual disability.
CHD2 -related neurodevelopmental disorders are characterized by early-onset epileptic encephalopathy (i.e., refractory seizures and cognitive slowing or regression associated with frequent ongoing epileptiform activit...
CHD2 myoclonic encephalopathy is a condition characterized by recurrent seizures (epilepsy), abnormal brain function (encephalopathy), and intellectual disability. Epilepsy begins in childhood, typically between ages ...
What is CHD2? The CHD2 gene is located on chromosome 15 and provides instructions for making a protein called chromodomain-DNA-helicase-binding protein 2. This protein is found in cells throughout the body and regulat...
Jan 14, 2026 · CHD2 (Chromodomain Helicase DNA Binding Protein 2) is a Protein Coding gene. Diseases associated with CHD2 include Developmental And Epileptic Encephalopathy 94 and Myoclonic-Atonic Epilepsy. Among its ...
CHD2 (chromodomain-helicase-DNA-binding protein 2) helps control the switching on and off of genes essential for brain development. Changes in the CHD2 gene can either be de novo (new in the person with epilepsy and n...
These models have provided crucial insight into the biology of CHD2 but scientific questions remain unanswered. A variety of therapeutic approaches have been proposed including novel treatments that directly target CH...
Nov 8, 2019 · Chromodomain helicase DNA binding protein 2 (Chd2) is a chromatin remodeller implicated in neurological disease.
Nov 25, 2024 · The CHD2 gene, located at chromosome 15q26.1, encodes chromodomain helicase DNA-binding protein 2 (CHD2), which is an ATP-dependent chromatin-remodeling enzyme.
